Moon, NJ
Aeryung Moon, Warren, NJ US
Patent application number | Description | Published |
---|---|---|
20080281957 | DEFERRED INVOCATION OF COMMUNICATION SERVICES - In one embodiment, a network device determines one or more conditions for invoking one or more real applications to the network device for a session. This determination may be made at the initiation of the session, such as when a SIP INVITE message is received. The one or more conditions allow real applications to be invoked when a future event satisfies the condition. When it is determined that a condition is satisfied, a real application associated with the condition is then invoked. Accordingly, conditions may be set for real applications that may be tested against future events that have not yet occurred. This allows deferred invocation of real applications. Accordingly, if real applications are not needed for a session, then they are not invoked. But, when a real application is needed, it can be invoked. | 11-13-2008 |
20110270997 | Deferred Invocation of Communication Services - In one embodiment, a network device determines one or more conditions for invoking one or more real applications to the network device for a session. This determination may be made at the initiation of the session, such as when a SIP INVITE message is received. The one or more conditions allow real applications to be invoked when a future event satisfies the condition. When it is determined that a condition is satisfied, a real application associated with the condition is then invoked. Accordingly, conditions may be set for real applications that may be tested against future events that have not yet occurred. This allows deferred invocation of real applications. Accordingly, if real applications are not needed for a session, then they are not invoked. But, when a real application is needed, it can be invoked. | 11-03-2011 |
Eric E. Moon, Fort Lee, NJ US
Patent application number | Description | Published |
---|---|---|
20090202055 | SYSTEM AND METHOD FOR PROVIDING PREPAID TELECOMMUNICATION SERVICES - The present invention relates to a system and method for providing prepaid telecommunication services. More particularly, prepaid telephone calls can be made by users without entering any access code, if such calls are made from telephone numbers previously registered in the telecommunication system in connection with valid access codes. Prepaid telephone calls can also be made from non-registered telephone numbers after providing the telecommunication system with a valid access code. | 08-13-2009 |
Grant Moon, Union City, NJ US
Patent application number | Description | Published |
---|---|---|
20150278971 | SYSTEM AND METHOD FOR FACILITATING REAL ESTATE SALES - A system and method that allows the creation of a network of realtors and lenders, which allows the lenders to keep the maximum number of pre-qualified buyers, and the network allows the realtors to receive clients from the network. The system, method, and network of the present invention can also match an original lender in one state and the buyer that is looking for a home in a different state with the local realtor that will help the buyer find a suitable property in the state the buyer is looking in, without diverting the buyer to a different lender. | 10-01-2015 |
Hong Mo Moon, Englewood Cliffs, NJ US
Patent application number | Description | Published |
---|---|---|
20090155308 | Powerful vaccine composition comprising lipopeptide and poly I:C as an adjuvant - The present invention relates to an adjuvant comprising a lipopeptide and poly I:C. When the adjuvant of the present invention is used, the level of antigen specific antibody induction is synergistically increased and Th1 type immune response is also induced. Therefore, the adjuvant of the present invention can be very effectively used as an adjuvant in the formulation of preventive and therapeutic vaccines for viral or parasitic infection and cancer. | 06-18-2009 |
20120202736 | SPRAY-DRIED COLLECTIN COMPOSITIONS AND PROCESS FOR PREPARING THE SAME - The present invention relates to a spray-dried composition comprising as an active ingredient at least one member protein of the collectin family or its functional equivalent for treating and preventing microbial infectious diseases. The present invention also relates to a method for producing the same composition. The composition produced by the method of the present invention is effective in suppressing infections caused by viruses, bacteria, fungi, and parasites. Since the composition is developed in a form suitable for inhalation, it can directly provide the active ingredient to the sites of infection from these microbes, and thus treat and prevent respiratory infections and external wounds. | 08-09-2012 |
Kooksang Moon, North Brunswick, NJ US
Patent application number | Description | Published |
---|---|---|
20090087070 | Method and system for bone suppression based on a single x-ray image - A method and system for suppressing bone structures based on a single x-ray image is disclosed. The bone structure suppressing method predicts a soft-tissue image without bone structures from an input x-ray image. A set of features is extracted for each pixel of the input x-ray image. A soft-tissue image is then generated from the input x-ray image using a trained regression function to determine an intensity value for the soft-tissue image corresponding to each pixel of the input x-ray image based on the set of features extracted for each pixel of the input x-ray image. The extracted features can be wavelet features and the regression function can be trained using Bayesian Committee Machine (BCM) to approximate Gaussian process regression (GPR). | 04-02-2009 |
Sung-Ju Moon, New Providence, NJ US
Patent application number | Description | Published |
---|---|---|
20100015046 | Camptothecin-Binding Moiety Conjugates - The invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a camptothecin as a therapeutic moiety, and further relates to processes for making and using the said conjugates. | 01-21-2010 |
20100104589 | Immunoconjugates with an Intracellularly-Cleavable Linkage - The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates. | 04-29-2010 |
20100233779 | Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites - The present invention concerns methods and compositions for delivery of therapeutic agents to target cells, tissues or organisms. In preferred embodiments, the therapeutic agents are delivered in the form of therapeutic-loaded polymers that may comprise many copies of one or more therapeutic agents. In more preferred embodiments, the polymer may be conjugated to a peptide moiety that contains one or more haptens, such as HSG. The agent-polymer-peptide complex may be delivered to target cells by, for example, a pre-targeting technique utilizing bispecific or multispecific antibodies or fragments, having at least one binding arm that recognizes the hapten and at least a second binding arm that binds specifically to a disease or pathogen associated antigen, such as a tumor associated antigen. Methods for synthesizing and using such therapeutic-loaded polymers and their conjugates are provided. | 09-16-2010 |
20110293513 | Immunoconjugates with an Intracellularly-Cleavable Linkage - The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates. | 12-01-2011 |
20120040431 | Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites - The present invention concerns methods and compositions for delivery of therapeutic agents to target cells, tissues or organisms. In preferred embodiments, the therapeutic agents are delivered in the form of therapeutic-loaded polymers that may comprise many copies of one or more therapeutic agents. In more preferred embodiments, the polymer may be conjugated to a peptide moiety that contains one or more haptens, such as HSG. The agent-polymer-peptide complex may be delivered to target cells by, for example, a pre-targeting technique utilizing bispecific or multispecific antibodies or fragments, having at least one binding arm that recognizes the hapten and at least a second binding arm that binds specifically to a disease or pathogen associated antigen, such as a tumor associated antigen. Methods for synthesizing and using such therapeutic-loaded polymers and their conjugates are provided. | 02-16-2012 |
20120082617 | Immunoconjugates with an Intracellularly-Cleavable Linkage - The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates. | 04-05-2012 |
20120328564 | Camptothecin-Binding Moiety Conjugates - The invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a camptothecin as a therapeutic moiety, and further relates to processes for making and using the said conjugates. | 12-27-2012 |
20130072659 | Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites - The present invention concerns methods and compositions for delivery of therapeutic agents to target cells, tissues or organisms. In preferred embodiments, the therapeutic agents are delivered in the form of therapeutic-loaded polymers that may comprise many copies of one or more therapeutic agents. In more preferred embodiments, the polymer may be conjugated to a peptide moiety that contains one or more haptens, such as HSG. The agent-polymer-peptide complex may be delivered to target cells by, for example, a pre-targeting technique utilizing bispecific or multispecific antibodies or fragments, having at least one binding arm that recognizes the hapten and at least a second binding arm that binds specifically to a disease or pathogen associated antigen, such as a tumor associated antigen. Methods for synthesizing and using such therapeutic-loaded polymers and their conjugates are provided. | 03-21-2013 |
20130090458 | Immunoconjugates with an Intracellularly-Cleavable Linkage - The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates. | 04-11-2013 |
20140058067 | Immunoconjugates with an Intracellularly-Cleavable Linkage - The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates. | 02-27-2014 |
20140099258 | Camptothecin-Binding Moiety Conjugates - The invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a camptothecin as a therapeutic moiety, and further relates to processes for making and using the said conjugates. | 04-10-2014 |
20140286860 | Immunoconjugates with an Intracellularly-Cleavable Linkage - The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates. | 09-25-2014 |
20140328752 | Immunoconjugates with an Intracellularly-Cleavable Linkage - The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates. | 11-06-2014 |
20150038686 | Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites - The present invention concerns methods and compositions for delivery of therapeutic agents to target cells, tissues or organisms. In preferred embodiments, the therapeutic agents are delivered in the form of therapeutic-loaded polymers that may comprise many copies of one or more therapeutic agents. In more preferred embodiments, the polymer may be conjugated to a peptide moiety that contains one or more haptens, such as HSG. The agent-polymer-peptide complex may be delivered to target cells by, for example, a pre-targeting technique utilizing bispecific or multispecific antibodies or fragments, having at least one binding arm that recognizes the hapten and at least a second binding arm that binds specifically to a disease or pathogen associated antigen, such as a tumor associated antigen. Methods for synthesizing and using such therapeutic-loaded polymers and their conjugates are provided. | 02-05-2015 |
20150174269 | Immunoconjugates with an Intracellularly-Cleavable Linkage - The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates. | 06-25-2015 |
20150174270 | Immunoconjugates with an Intracellularly-Cleavable Linkage - The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates. | 06-25-2015 |
20150182633 | Immunoconjugates with an Intracellularly-Cleavable Linkage - The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates. | 07-02-2015 |
Sung Sub Moon, Edgewater, NJ US
Patent application number | Description | Published |
---|---|---|
20140101069 | CARGO HANDLING SERVICES AND SYSTEMS - The present invention related to a system and computer-implemented method directed to cargo handling services. A stakeholder captures airline data and customer related cargo data and transmits the data to at least one other stakeholder through either a customer service portal or a mobile warehouse management system. The system is a cargo management system comprising three parts. First, a messaging engine adapted to transmit airline data. Second, a customer service portal receives data from the messaging engine for a stakeholder, such that the stakeholder may manage, track, or reconcile a cargo shipment. Finally, a mobile warehouse management system implemented for recording data and tracking cargo in real-time. | 04-10-2014 |
Yongsik Moon, Paramus, NJ US
Patent application number | Description | Published |
---|---|---|
20100267318 | POLISHING PAD WITH PROJECTING PORTION - A polishing pad include a polishing layer having a polishing surface and a backing layer on a side of the polishing layer opposite the polishing surface. An outer edge of the polishing layer overhangs an outer edge of the backing layer. | 10-21-2010 |
20110086445 | METHODS RELATING TO CAPACITIVE MONITORING OF LAYER CHARACTERISTICS DURING BACK END-OF-THE-LINE PROCESSING - Methods are provided that relate to the capacitive monitoring of characteristic pertaining to layer formed during the back end-of-the-line (BEOL) processing of a semiconductor device. In one embodiment, a method includes the steps of forming a first capacitor array including first and second overlying contacts each formed in a different one of the plurality of BEOL layers, measuring the interlayer capacitance between the first and second overlying contacts, and converting the measured interlayer capacitance to a distance between the first and second overlying contacts. | 04-14-2011 |
Yongsoon Moon, River Edge, NJ US
Patent application number | Description | Published |
---|---|---|
20100102475 | EXPANDED POLYSTYRENE RECYCLING AND HEAT EXTRUDING SYSTEM - An expanded polystyrene (EPS) recycling and extruding machine is shown and described. The machine comprises a conveyor for transporting waste pieces of EPS of various sizes into the device. A housing surrounds upper and lower crushers that break down the EPS pieces in to progressively smaller pieces before depositing them through a screen that selectively prevents pieces above a predetermined size from passing. Below the screen, the small EPS pieces fall into a heated extruding mechanism that melts the pieces into a liquid and urges the liquid forward by means of an Archimedian screw to a nozzle, through which the reconstituted EPS is extruded for collection and reuse. | 04-29-2010 |
Young-Choon Moon, Belle Meade, NJ US
Patent application number | Description | Published |
---|---|---|
20110046136 | METHODS FOR THE PRODUCTION OF FUNCTIONAL PROTEIN FROM DNA HAVING A NONSENSE MUTATION AND THE TREATMENT OF DISORDERS ASSOCICATED THEREWITH - The present invention relates to functional proteins encoded by nucleic acid sequences comprising a nonsense mutation. The present invention also relates to methods for the production of functional proteins encoded by nucleic acid sequences comprising a nonsense mutation and the use of such proteins for prevention, management and/or treatment of diseases associated with a nonsense mutation(s) in a gene. | 02-24-2011 |